<!doctype html public "-//W3C//DTD W3 HTML//EN">
<html><head><style type="text/css"><!--
blockquote, dl, ul, ol, li { margin-top: 0 ; margin-bottom: 0 }
--></style><title>Fwd: BMES Distinguished Lecture Series May
19th</title></head><body>
<blockquote type="cite" cite>
<blockquote type="cite" cite>Dear colleagues and friends,<br>
<br>
The Boston chapter of the Institute of Electrical and Electronics
Engineers<br>
(IEEE)-Engineering in
Medicine and Biology Society (EMBS)<br>
<span
></span
> <span
></span>
&<br>
<span
></span> the MIT Biomedical Engineering Society (BMES)<br>
<span
></span
> <span
></span> proudly present:<br>
<br>
*** The 2003-2004 EMBS-BMES
Distinguished Lecture Series ***<br>
<br>
We invite you to join us for our new monthly lecture series in which
we explore<br>
recent developments and stimulating topics in the expanding field of
biomedical<br>
engineering. In the spring, speakers from both academia and
industry will introduce such<br>
subjects as genes, genomics, proteomics, and systems biology.<br>
<br>
Our ninth lecture will be:<br>
<br>
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<span
></span>~~~~~~~~~~~~~~~~~~~~~<br>
<b>Moving from Discovery Insight to Market in MA: OR Every Biotech
Blockbuster Needs a Cluster of Supporting Stars<br>
</b><font
face="Arial">~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~</font
>~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~<br>
<br>
Mr. Mark Trusheim<br>
Interim President, Massachusetts BioTechnology Council (MBC)<br>
Cambridge, MA<br>
<br>
<font face="Arial">Wednesday, May 19th, 2004<br>
7PM (Refreshments at 6:30PM)<br>
MIT Building 66, 25 Ames Street, Room 66-110<br>
(For directions to MIT, please visit<font color="#0000FF"><u>
http://whereis.mit.edu</u></font>)<br>
<br>
* This event is free and open to the public.*<br>
<br>
*********************************************************************<span
></span>***<br>
<br>
ABSTRACT:<br>
<br>
</font>The process from a fundamental scientific insight to a
therapeutic that helps millions of patients around the world is
journey filled with science, applied engineering, financial
engineering, politics, insurers and intrigue. Along the way to
becoming an award winning blockbuster therapy, every biotech product
requires a supporting cast of dozens of stars over at least a
decade.<br>
<br>
<font face="Arial">SPEAKER BACKGROUND:<br>
<br>
</font>Mark Trusheim is currently serving as the Interim President of
the Massachusetts Biotechnology Council (MBC) where he has also served
on the Board of Directors for the past 4 years. Mark is the Founder
and was the first President and CEO of Cantata Laboratories. Cantata
markets clinical diagnostics and pharmaceutical biomarker services
based on its biochemical profiling platform. Prior to Cantata, Mark
spent over 10 years at Monsanto, culminating his career there as
Co-President and Chief Operating Officer of Cereon Genomics, LLC.
Located in Cambridge, Massachusetts, Cereon was created in 1997 by
Monsanto to collaborate with Millennium Pharmaceuticals to improve the
world's crops through the use of Genomics. Prior to his position at
Cereon, Mark was responsible for Monsanto's external genomics
relationships and held roles of Vice President in the Health &
Wellness Sector, Marketing Director in Searle Pharmaceutical and
Director in Agriculture Division Strategy. Prior to entering the life
sciences industry, Mark spent the first half of his career in the
computer industry working at both Wang Laboratories in computer
hardware and the start-up Kenan Systems Corporation in software
services. He holds degrees in Chemistry from Stanford University and
Management from MIT.<br>
<br>
<br>
<font
face="Arial"
>********************************************************************<span
></span>****<br>
<br>
</font>If you have any questions, please do not hesitate to contact
us. We look<br>
forward to seeing you!<br>
<br>
<br>
Best Regards,<br>
<br>
Mandy Yeung<x-tab>
</x-tab><x-tab>
</x-tab><x-tab>
</x-tab><x-tab>
</x-tab><x-tab>
</x-tab>Alexis DeSieno<br>
VP of Special Programs<x-tab>
</x-tab><x-tab>
</x-tab><x-tab>
</x-tab>President<br>
BMES,MIT Chapter<x-tab>
</x-tab><x-tab>
</x-tab><x-tab>
</x-tab><x-tab>
</x-tab>BMES, MIT Chapter<br>
mandyy@mit.edu<x-tab>
</x-tab><x-tab>
</x-tab><x-tab>
</x-tab><x-tab>
</x-tab>alexisd@mit.edu<br>
<br>
<font face="Century Gothic" color="#800080"><b>M a n d y Y e u n
g<br>
</b>MIT Biology, c/o 05<br>
<font size="-1">410 memorial drive rm 451-a<br>
cambridge, ma 02139<br>
tel: (617) 794-1431</font></font></blockquote>
</blockquote>
<div><br></div>
</body>
</html>